Early and broadly defined psychosis risk mental states

Schizophrenia Research

Volumn 126, Issue 1-3, 2011, Pages 1-10

  Keshavan, Matcheri S ^a,c   DeLisi, Lynn E ^b,c   Seidman, Larry J ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

At risk mental state; Cognition; Genetic risk; Psychosis; Schizophrenia

Indexed keywords

PHOSPHORUS;

ARTICLE; BRAIN FUNCTION; COGNITIVE DEFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC RISK; HUMAN; MENTAL DETERIORATION; MENTAL DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SOCIAL DISABILITY; SOCIAL ISOLATION; SYMPTOMATOLOGY;

BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 79952009094     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.006     Document Type: Article

References (100)

1. Amminger G.P., Pape S., Rock D., Roberts S.A., Ott S.L., Squires-Wheeler E., et al. Relationship between childhood behavioral disturbance and later schizophrenia in the New York high-risk project. Am. J. Psychiatry 1999, 156(4):525-530.
2. Barbour T., Murphy E., Pruitt P., Eickhoff S.B., Keshavan M.S., Rajan U., et al. Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring. Schizophr. Res. 2010, 123(2-3):126-136.
3. Bechdolf A., Ruhrmann S., Wagner M., Kuhn K.U., Janssen B., Bottlender R., et al. Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. Br. J. Psychiatry Suppl. 2005, 48:s45-s48.
4. Bertisch H., Li D., Hoptman M.J., Delisi L.E. Heritability estimates for cognitive factors and brain white matter integrity as markers of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(4):885-894.
5. Bhojraj T.S., Diwadkar V.A., Sweeney J.A., Prasad K.M., Eack S.M., Montrose D.M., et al. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(3):469-474.
6. Bhojraj T.S., Sweeney J.A., Prasad K.M., Eack S., Rajarethinam R., Francis A.N., et al. Progressive alterations of the auditory association areas in young non-psychotic offspring of schizophrenia patients. J. Psychiatr. Res. 2010, [Jun 10, Electronic publication ahead of print].
7. Callicott J.H., Egan M.F., Bertolino A., Mattay V.S., Langheim F.J., Frank J.A., et al. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol. Psychiatry 1998, 44(10):941-950.
8. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
9. Cecil K.M., DelBello M.P., Sellars M.C., Strakowski S.M. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J. Child Adolesc. Psychopharmacol. 2003, 13(4):545-555.
10. Chapman L.J., Chapman J.P. The search for symptoms predictive of schizophrenia. Schizophr. Bull. 1987, 13(3):497-503.
11. Cicchetti D., Rogosch F.A. A developmental psychopathology perspective on adolescence. J. Consult. Clin. Psychol. 2002, 70(1):6-20.
12. Cohen A.S., Leung W.W., Saperstein A.M., Blanchard J.J. Neuropsychological functioning and social anhedonia: results from a community high-risk study. Schizophr. Res. 2006, 85(1-3):132-141.
13. Cornblatt B.A., Lencz T., Kane J.M. Treatment of the schizophrenia prodrome: is it presently ethical?. Schizophr. Res. 2001, 51(1):31-38.
14. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 2003, 29(4):633-651.
15. Cosway R., Byrne M., Clafferty R., Hodges A., Grant E., Abukmeil S.S., et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol. Med. 2000, 30(5):1111-1121.
16. DeLisi L.E., Goldin L.R., Hamovit J.R., Maxwell M.E., Kurtz D., Gershon E.S. A family study of the association of increased ventricular size with schizophrenia. Arch. Gen. Psychiatry 1986, 43(2):148-153.
17. DeLisi L.E., Szulc K.U., Bertisch H., Majcher M., Brown K., Bappal A., et al. Early detection of schizophrenia by diffusion weighted imaging. Psychiatry Res. 2006, 148(1):61-66.
18. Diwadkar V.A., Montrose D.M., Dworakowski D., Sweeney J.A., Keshavan M.S. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30(2):230-238.
19. Doyle A.E., Biederman J., Seidman L.J., Weber W., Faraone S.V. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder. J. Consult. Clin. Psychol. 2000, 68(3):477-488.
20. Dworkin R.H., Bernstein G., Kaplansky L.M., Lipsitz J.D., Rinaldi A., Slater S.L., et al. Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. Am. J. Psychiatry 1991, 148(9):1182-1188.
21. Dworkin R.H., Lewis J.A., Cornblatt B.A., Erlenmeyer-Kimling L. Social competence deficits in adolescents at risk for schizophrenia. J. Nerv. Ment. Dis. 1994, 182(2):103-108.
22. Eack S.M.D.E.M., Montrose D.M., Miewald J., Gur R.E., Gur R.C., et al. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr. Bull. 2010, 36(6):1081-1088.
23. Eastvold A.D., Heaton R.K., Cadenhead K.S. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr. Res. 2007, 93(1-3):266-277.
24. Faraone S.V., Green A.I., Seidman L.J., Tsuang M.T. "Schizotaxia": clinical implications and new directions for research. Schizophr. Bull. 2001, 27(1):1-18.
25. Filakovic P., Degmecic D., Koic E., Benic D. Ethics of the early intervention in the treatment of schizophrenia. Psychiatr. Danub. 2007, 19(3):209-215.
26. Fish B. Infant predictors of the longitudinal course of schizophrenic development. Schizophr. Bull. 1987, 13(3):395-409.
27. Frangou S., Haldane M., Roddy D., Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol. Psychiatry 2005, 58(10):838-839.
28. Frommann I., Pukrop R., Brinkmeyer J., Bechdolf A., Ruhrmann S., Berning J., et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early - and additional memory dysfunction in the late - prodromal state. Schizophr. Bull. 2010, [Jan 6, Electronic publication ahead of print].
29. Gallelli K.A., Wagner C.M., Karchemskiy A., Howe M., Spielman D., Reiss A., et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord. 2005, 7(6):589-597.
30. Giles L.L., DelBello M.P., Stanford K.E., Strakowski S.M. Child behavior checklist profiles of children and adolescents with and at high risk for developing bipolar disorder. Child Psychiatry Hum. Dev. 2007, 38(1):47-55.
31. Glatt S.J., Stone W.S., Faraone S.V., Seidman L.J., Tsuang M.T. Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br. J. Psychiatry 2006, 189:337-345.
32. Haas G.L., Sweeney J.A. Premorbid and onset features of first-episode schizophrenia. Schizophr. Bull. 1992, 18(3):373-386.
33. Hafner H., Maurer K. Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry 2006, 5(3):130-138.
34. Hafner H., Loffler W., Maurer K., Hambrecht M., an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr. Scand. 1999, 100(2):105-118.
35. Haroun N., Dunn L., Haroun A., Cadenhead K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr. Bull. 2006, 32(1):166-178.
36. Hoff A.L., Svetina C., Maurizio A.M., Crow T.J., Spokes K., DeLisi L.E. Familial cognitive deficits in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 133B(1):43-49.
37. Hoptman M.J., Nierenberg J., Bertisch H.C., Catalano D., Ardekani B.A., Branch C.A., et al. A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophr. Res. 2008, 106(2-3):115-124.
38. Huber G., Gross G. The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recenti Prog. Med. 1989, 80:646-652.
39. Jahshan C., Heaton R.K., Golshan S., Cadenhead K.S. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology 2010, 24(1):109-120.
40. Job D., Whalley H.C., Johnstone E.C., Lawrie S.M. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005, 25:1023-1030.
41. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br. J. Psychiatry 2005, 186:18-25.
42. Keshavan M.S. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J. Psychiatr. Res. 1999, 33(6):513-521.
43. Keshavan M.S., Dick E., Mankowski I., Harenski K., Montrose D.M., Diwadkar V., et al. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr. Res. 2002, 58(2-3):173-183.
44. Keshavan M.S., Diwadkar V.A., Spencer S.M., Harenski K.A., Luna B., Sweeney J.A. A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26(6):1143-1149.
45. Keshavan M.S., Stanley J.A., Montrose D.M., Minshew N.J., Pettegrew J.W. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol. Psychiatry 2003, 8(3):316-323. (251).
46. Keshavan M.S., Diwadkar V.A., Montrose D.M., Rajarethinam R., Sweeney J.A. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr. Res. 2005, 79(1):45-57.
47. Keshavan M., Montrose D.M., Rajarethinam R., Diwadkar V., Prasad K., Sweeney J.A. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr. Res. 2008, 103(1-3):114-120.
48. Keshavan M.S., Dick R.M., Diwadkar V.A., Montrose D.M., Prasad K.M., Stanley J.A. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study. Schizophr. Res. 2009, 115(1):88-93.
49. Keshavan M.S., Kulkarni S., Bhojraj T., Francis A., Diwadkar V., Montrose D.M., et al. Premorbid cognitive deficits in young relatives of schizophrenia patients. Front. Hum. Neurosci. 2010, 3:62.
50. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry 2001, 58(2):158-164.
51. Lataster T., Myin-Germeys I., Derom C., Thiery E., van Os J. Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(8):1078-1084.
52. Li X., Branch C.A., Ardekani B.A., Bertisch H., Hicks C., DeLisi L.E. fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk. Schizophr. Res. 2007, 96(1-3):14-24.
53. Luyten P., Vliegen N., Van Houdenhove B., Blatt S.J. Equifinality, multifinality, and the rediscovery of the importance of early experiences: pathways from early adversity to psychiatric and (functional) somatic disorders. Psychoanal. Study Child 2008, 63:27-60.
54. Marcus J., Hans S.L., Auerbach J.G., Auerbach A.G. Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age. Arch. Gen. Psychiatry 1993, 50(10):797-809.
55. Maurer K., Hafner H. Methodological aspects of onset assessment in schizophrenia. Schizophr. Res. 1995, 15(3):265-276.
56. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch. Gen. Psychiatry 2004, 61(10):974-984.
57. MacDonald A.W., Thermenos H.W., Barch D.M., Seidman L.J. Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives. Schizophr. Bull. 2009, 35(6):1142-1162.
58. McGlashan T.H., Miller T.J., Woods S.W., et al. Structured Interview for Prodromal Syndromes (Version 3.0, unpublished manuscript) 2001, PRIME Research Clinic, Yale School of Medicine, New Haven, Connecticut.
59. McGorry P.D., Purcell R., Hickie I.B., Yung A.R., Pantelis C., Jackson H.J. Clinical staging: a heuristic model for psychiatry and youth mental health. Med. J. Aust. 2007, 187(7 Suppl):S40-S42.
60. McNeil T.F., Harty B., Blennow G., Cantor-Graae E. Neuromotor deviation in offspring of psychotic mothers: a selective developmental deficiency in two groups of children at heightened psychiatric risk?. J. Psychiatr. Res. 1993, 27(1):39-54.
61. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23(3):315-336.
62. Miller P.M., Byrne M., Hodges A., Lawrie S.M., Johnstone E.C. Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk study. Psychol. Med. 2002, 32(1):173-179.
63. Miller P.M., Lawrie S.M., Byrne M., Cosway R., Johnstone E.C. Self-rated schizotypal cognitions, psychotic symptoms and the onset of schizophrenia in young people at high risk of schizophrenia. Acta Psychiatr. Scand. 2002, 105(5):341-345.
64. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
65. Niendam T.A., Bearden C.E., Johnson J.K., McKinley M., Loewy R., O'Brien M., et al. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr. Res. 2006, 84(1):100-111.
66. Owens D.G., Johnstone E.C. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context. Psychol. Med. 2006, 36(11):1501-1514.
67. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-288.
68. Phillips L.K., Seidman L.J. Emotion processing in persons at risk for schizophrenia. Schizophr. Bull. 2008, 34(5):888-903.
69. Platz C., Umbricht D.S., Cattapan-Ludewig K., Dvorsky D., Arbach D., Brenner H.D., et al. Help-seeking pathways in early psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2006, 41(12):967-974.
70. Prasad K.M., Keshavan M.S. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?. Schizophr. Bull. 2008, 34(4):774-790.
71. Pukrop R., Klosterkotter J. Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence. Neurotox. Res. 2010, 18(3-4):272-286.
72. Rajarethinam R., Sahni S., Rosenberg D.R., Keshavan M.S. Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. Am. J. Psychiatry 2004, 161(6):1121-1124.
73. Rajarethinam R., Upadhyaya A., Tsou P., Upadhyaya M., Keshavan M.S. Caudate volume in offspring of patients with schizophrenia. Br. J. Psychiatry 2007, 191:258-259.
74. Rosso I.M., Makris N., Thermenos H.W., Hodge S.M., Brown A., Kennedy D., et al. Regional prefrontal cortex gray matter volumes in youth at familial risk for schizophrenia from the Harvard Adolescent High Risk Study. Schizophr. Res. 2010, 123(1):15-21.
75. Ruhrmann S., Schultze-Lutter F., Salokangas R.K., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch. Gen. Psychiatry 2010, 67(3):241-251.
76. Sass L.A., Parnas J. Schizophrenia, consciousness, and the self. Schizophr. Bull. 2003, 29(3):427-444.
77. Schmael C., Georgi A., Krumm B., Buerger C., Deschner M., Nothen M.M., et al. Premorbid adjustment in schizophrenia - an important aspect of phenotype definition. Schizophr. Res. 2007, 92(1-3):50-62.
78. Seidman L.J., Pantelis C., Keshavan M.S., Faraone S.V., Goldstein J.M., Horton N.J., et al. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr. Bull. 2003, 29(4):803-830.
79. Seidman L.J., Giuliano A.J., Smith C.W., Stone W.S., Glatt S.J., Meyer E., et al. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr. Bull. 2006, 32(3):507-524.
80. Seidman L.J., Thermenos H.W., Poldrack R.A., Peace N.K., Koch J.K., Faraone S.V., et al. Altered brain activation in dorsolateral prefrontal cortex in adolescents and young adults at genetic risk for schizophrenia: an fMRI study of working memory. Schizophr. Res. 2006, 85(1-3):58-72.
81. Seidman L.J., Giuliano A.J., Meyer E.C., Addington J., Cadenhead K.S., Cannon T.D., et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry 2010, 67(6):578-588.
82. Shedlack K., Lee G., Sakuma M., Xie S.H., Kushner M., Pepple J., et al. Language processing and memory in ill and well siblings from multiplex families affected with schizophrenia. Schizophr. Res. 1997, 25(1):43-52.
83. Simon A.E., Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr. Res. 2010, 116(2-3):168-172.
84. Simon A.E., Cattapan-Ludewig K., Zmilacher S., Arbach D., Gruber K., Dvorsky D.N., et al. Cognitive functioning in the schizophrenia prodrome. Schizophr. Bull. 2007, 33(3):761-771.
85. Stone W.S., Faraone S.V., Seidman L.J., Olson E.A., Tsuang M.T. Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents. J. Child Adolesc. Psychopharmacol. 2005, 15(3):403-417.
86. Stone J.M., Day F., Tsagaraki H., Valli I., McLean M.A., Lythgoe D.J., et al. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol. Psychiatry 2009, 66(6):533-539.
87. Sullivan H.S. The onset of schizophrenia. 1927. Am. J. Psychiatry 1994, 151(6 Suppl):134-139.
88. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2009, 108(1-3):85-92.
89. Takahashi T., Wood S.J., Yung A.R., Soulsby B., McGorry P.D., Suzuki M., et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch. Gen. Psychiatry 2009, 66(4):366-376.
90. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 2009, 110(1-3):1-23.
91. Tarbox S.I., Pogue-Geile M.F. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol. Bull. 2008, 134(4):561-583.
92. Thermenos H.W., Seidman L.J., Poldrack R.A., Peace N.K., Koch J.K., Faraone S.V., et al. Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI. Biol. Psychiatry 2007, 61(4):564-574.
93. Whalley H.C., Gountouna V.E., Hall J., McIntosh A., Whyte M.C., Simonotto E., et al. Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia. BMC Psychiatry 2007, 7:61.
94. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc. Natl Acad. Sci. USA 2009, 106(4):1279-1284.
95. Whyte M.C., Brett C., Harrison L.K., Byrne M., Miller P., Lawrie S.M., et al. Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol. Psychiatry 2006, 59(8):730-739.
96. Woodberry K.A., Giuliano A.J., Seidman L.J. Premorbid IQ in schizophrenia: a meta-analytic review. Am. J. Psychiatry 2008, 165(5):579-587.
97. Woods S.W., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull. 2009, 35(5):894-908.
98. Woods E.R., Buka S.L., Martin C.R., Salganik M., Howard M.B., Gueguen J.A., et al. Assessing youth risk behavior in a clinical trial setting: lessons from the infant health and development program. J. Adolesc. Health 2010, 46(5):429-436.
99. Yoo S.Y., Yeon S., Choi C.H., Kang D.H., Lee J.M., Shin N.Y., et al. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus. Schizophr. Res. 2009, 111(1-3):86-93.
100. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr. Bull. 1996, 22(2):353-370.